Research Topics
| Tim CundySummaryAffiliation: University of Auckland Country: New Zealand Publications
| Collaborators
|
Detail Information
Publications
Reprint: Paget's disease of boneTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Clin Biochem 45:970-5. 2012..To review recent advance in understanding the causation and management of Paget's disease...
Recent advances in osteogenesis imperfectaTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
Calcif Tissue Int 90:439-49. 2012....
Proposed new diagnostic criteria for gestational diabetes--a pause for thought?T Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
Diabet Med 29:176-80. 2012..Given the many reservations about the new criteria an urgent but dispassionate debate is required on the risks, costs and benefits of their introduction...
Paget's disease of boneTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Clin Biochem 45:43-8. 2012..To review recent advance in understanding the causation and management of Paget's disease...
Evidence for secular change in Paget's diseaseT Cundy
Department of Medicine, University of Auckland Medical School, New Zealand
Bone 20:69-71. 1997..Our data demonstrate that, on average, newly referred patients with Paget's disease have less severe disease and are significantly older at diagnosis than was the case two decades ago...
Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapyTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
J Bone Miner Res 19:703-11. 2004..Their youngest affected sibling was treated intensively with intravenous bisphosphonates for 3 years. The treatment was well tolerated and prevented the development of deformity and disability...
Familial Paget disease and SQSTM1 mutations in New ZealandTim Cundy
Department of Medicine, University of Auckland, New Zealand
Calcif Tissue Int 89:258-64. 2011..005). SQSTM1 mutations were found in 10.5% of patients with early onset and/or severe disease but no family history...
Severe hypomagnesaemia in long-term users of proton-pump inhibitorsT Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
Clin Endocrinol (Oxf) 69:338-41. 2008..To explore the mechanism underlying severe hypomagnesaemia in long-term users of proton-pump inhibitors (PPIs)...
Differing causes of pregnancy loss in type 1 and type 2 diabetesTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
Diabetes Care 30:2603-7. 2007..Women with type 2 and type 1 diabetes have differing risk factors for pregnancy loss. We compared the rates and causes of pregnancy loss in women with type 1 and type 2 diabetes...
Is the prevalence of Paget's disease of bone decreasing?Tim Cundy
Department of Medicine, University of Auckland, Auckland, New Zealand
J Bone Miner Res 21:P9-13. 2006..Paget's disease has become less prevalent and patients are presenting later, with less severe disease than previously. These data suggest that environmental factors are important in the etiology of Paget's disease...
Is Paget's disease of bone disappearing?T Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, 1001, New Zealand
Skeletal Radiol 35:350-1. 2006
Paget disease of boneTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
Trends Endocrinol Metab 19:246-53. 2008..Most observations seem to fit best with the idea that Paget disease behaves as a multifocal benign neoplasm...
Proton pump inhibitors and severe hypomagnesaemiaTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
Curr Opin Gastroenterol 27:180-5. 2011..We reviewed all the cases published to date in peer-reviewed journals to summarize what is known of the epidemiology, risk factors, cause and treatment...
Bone formation markers in adults with mild osteogenesis imperfectaTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
Clin Chem 53:1109-14. 2007..Plasma concentrations of procollagen peptides are decreased in osteogenesis imperfecta (OI), whereas other bone formation markers may be increased. We examined the utility of combining these markers in the diagnosis of OI in adults...
Idiopathic hyperphosphatasiaTim Cundy
Department of Medicine, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
Semin Musculoskelet Radiol 6:307-12. 2002..Treatment with inhibitors of bone resorption (calcitonin or bisphosphonates) is successful in ameliorating some aspects of the disorder...
A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetateTim Cundy
Department of Medicine, Faculty of Medicine and Health Science, University of Auckland, 1001 Auckland, New Zealand
J Clin Endocrinol Metab 88:78-81. 2003..0%, P = 0.029). There were no major adverse events. These data support the view that the likely cause of DMPA-associated bone loss is estrogen deficiency and demonstrate that it can be arrested by estrogen replacement therapy...
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotypeTim Cundy
Department of Medicine, Faculty of Medicine and Health Science, University of Auckland, New Zealand
Hum Mol Genet 11:2119-27. 2002..This description of abnormal OPG function in humans expands the spectrum of genetic bone diseases arising from perturbations of the OPG/RANK-L/RANK system that regulates osteoclastogenesis...
Hypertensive disorders of pregnancy in women with Type 1 and Type 2 diabetesT Cundy
Department of Medicine, Faculty of Medicine and Health Sciences, University of Auckland and, Diabetes Pregnancy Clinic, National Women s Hospital, Auckland, New Zealand
Diabet Med 19:482-9. 2002..The aim of this study was to compare the incidence and outcomes of, and risk factors for, hypertension in pregnancy in women with Type 1 and Type 2 diabetes...
Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraceptionTim Cundy
Department of Medicine, Faculty of Medicine and Health Science, The University of Auckland, and the Family Planning Association of New Zealand
Am J Obstet Gynecol 186:978-83. 2002..The purpose of this study was to determine the rate of early postmenopausal bone loss in women who had used depot medroxyprogesterone acetate contraception through to menopause...
Spinal bone density in women using depot medroxyprogesterone contraceptionT Cundy
Department of Medicine, The Faculty of Medicine and Health Sciences, University of Auckland, New Zealand
Obstet Gynecol 92:569-73. 1998..To determine factors possibly associated with reduced bone density in women using the injectable contraceptive depot medroxyprogesterone acetate...
Perinatal mortality in Type 2 diabetes mellitusT Cundy
Department of Medicine, University of Auckland, New Zealand
Diabet Med 17:33-9. 2000..This study reports observational data on perinatal mortality in Type 2 DM from a population with a high background rate of this disorder...
Absence of somatic SQSTM1 mutations in Paget's disease of boneBrya G Matthews
Department of Medicine, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
J Clin Endocrinol Metab 94:691-4. 2009..Therefore, we examined the possibility that somatic mutations in the SQSTM1 gene are present in the local lesions, using RNA collected from primary osteoblast and bone marrow cell cultures of patients with this condition...
Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trialIan R Reid
Department of Medicine, University of Auckland, Auckland, New Zealand
J Clin Endocrinol Metab 92:2446-52. 2007..EXPERIMENTAL SUBJECTS: Subjects included 80 women with postmenopausal osteoporosis who had been taking estrogen for at least 1 yr...
Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's diseaseBrya G Matthews
Department of Medicine, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
J Clin Endocrinol Metab 93:1398-401. 2008..We have tested for measles virus sequences in osteoblasts and bone marrow cells collected from pagetic lesions and healthy bone...
Recombinant osteoprotegerin for juvenile Paget's diseaseTim Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
N Engl J Med 353:918-23. 2005..Apart from mild hypocalcemia and hypophosphatemia, no apparent adverse events occurred...
Increased abdominal fat in young women of Indian originBrandon Orr-Walker
Department of Medicine, Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
Asia Pac J Clin Nutr 14:69-73. 2005..001), with marked differences evident even in the youngest group (mean age 23 years). Compared to other racial groups, women of Indian origin preferentially accumulate abdominal fat--a trait that is well established in young adulthood...
Delayed development of Paget's disease in offspring inheriting SQSTM1 mutationsMark J Bolland
Department of Medicine, University of Auckland, New Zealand
J Bone Miner Res 22:411-5. 2007..At any given age, the offspring were less likely to be diagnosed with Paget's disease and had less severe disease than their parents...
Should measurement of vitamin D and treatment of vitamin D insufficiency be routine in New Zealand?Mark J Bolland
Bone and Joint Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
N Z Med J 125:83-91. 2012..Therefore, a move away from routine vitamin D measurements seems sensible, though they are still indicated when investigating suspected metabolic bone disease or hypocalcaemia...
Insulin sensitivity in the offspring of women with type 1 and type 2 diabetesWendy A Hunter
Liggins Institute, Faculty of Medicine and Health Sciences, The University of Auckland, Auckland, New Zealand
Diabetes Care 27:1148-52. 2004..To determine if insulin sensitivity is altered in prepubertal offspring exposed to a diabetic intrauterine environment...
Osteonecrosis of the jawIan R Reid
Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
Skeletal Radiol 38:5-9. 2009..Obvious abnormalities are apparent with a variety of radiologic modalities, and it is not clear that radiographs are inferior to other approaches. Most authors favor a conservative approach to surgical debridement of the lesions...
Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspectiveMark Bolland
Department of Medicine, University of Auckland
N Z Med J 119:U2339. 2006..The aim of this article is to put the risks of osteonecrosis of the jaw into context with the benefits of bisphosphonate treatment in these clinical scenarios...
Paget's disease of bone in New Zealand: continued decline in disease severityH R Cundy
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Calcif Tissue Int 75:358-64. 2004..Although there are a number of potential biases, these data are consistent with a continued secular trend to presentation in older subjects with less extensive skeletal involvement, and a declining prevalence of Paget's disease...
Understanding the new HbA1c units for the diagnosis of Type 2 diabetesGeoff D Braatvedt
Department of Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
N Z Med J 125:70-80. 2012..For patients whose HbA1c is less than and equal to 40 mmol/mol, repeat screening (including for CVD risk) at intermittent intervals is recommended as per published guidelines...
Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of boneIan R Reid
Department of Medicine, University of Auckland, Private Bag 92019, New Zealand
Bone 35:224-30. 2004..There is no clear evidence from this study that any of these newer markers are superior to total AP in assessing patients with this severity of Paget's disease...
Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of boneDorit Naot
Department of Medicine, University of Auckland, New Zealand
J Bone Miner Res 22:298-309. 2007..We identified several differentially regulated genes, and we suggest that these changes could lead to the formation of the lesions...
Paget's disease of bone--becoming a rarity?Sonja Bastin
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1020, New Zealand
Rheumatology (Oxford) 48:1232-5. 2009..We undertook a radiographic survey to determine the current prevalence of Paget's disease in New Zealand (previously recognized as a high prevalence area)...
Peak bone mass after exposure to antenatal betamethasone and prematurity: follow-up of a randomized controlled trialStuart R Dalziel
Clinical Trials Research Unit, University of Auckland, Auckland, New Zealand
J Bone Miner Res 21:1175-86. 2006..Birth weight and prematurity predict adult height, but it is slower fetal growth, rather than prematurity, that predicts lower peak bone mass. The lower peak bone mass in those born small is appropriate for their adult height...
Increasing prevalence of type 2 diabetes in adolescentsS Hotu
Auckland Diabetes Centre, Auckland, New Zealand
J Paediatr Child Health 40:201-4. 2004..Adverse cardiovascular risk factors are prevalent in this population. Public health measures to curtail the rise of obesity in childhood and adolescence are required urgently...
Long-term maternal outcome after pregnancy in women with diabetic nephropathyWarwick Bagg
Pregnancy Diabetes Clinic, National Women's Hospital and Department of Medicine, University of Auckland, Auckland, New Zealand
N Z Med J 116:U566. 2003
Metformin versus insulin for the treatment of gestational diabetesJanet A Rowan
National Women s Health, Auckland City Hospital, Grafton, Auckland, New Zealand
N Engl J Med 358:2003-15. 2008..Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking...
Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetesT Farrell
Department of Medicine, Faculty of Medicine and Health Sciences, University of Auckland, New Zealand
Diabet Med 19:322-6. 2002..In the remainder of the GDM group, the rate does not differ from the non-diabetic background rate...
Paget's disease in patients of Asian descent in New ZealandShyam Sankaran
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Aukland, New Zealand
J Bone Miner Res 27:223-6. 2012..It also implies that the apparent reduction in Paget's disease prevalence in western cities is unlikely to be explicable by the rising Asian population of these cities...
The effect of an apparent change to a branded or generic medication on drug effectiveness and side effectsKate Faasse
Department of Psychological Medicine, University of Auckland, Auckland 1142, New Zealand
Psychosom Med 75:90-6. 2013..This study examined the effect of an apparent medication formulation change on subjective and objective measures of medication effectiveness and medication side effects...
Ocular manifestations of juvenile Paget diseaseNathan M Kerr
Department of Ophthalmology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
Arch Ophthalmol 128:698-703. 2010..To determine the prevalence and spectrum of retinal changes in juvenile Paget disease...
Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetesR Singh
Auckland Diabetes Centre, Auckland, New Zealand
Diabet Med 22:625-30. 2005..To determine the lifetime risk of developing symptomatic carpal tunnel syndrome (CTS) in subjects with Type 1 diabetes and to investigate the effect of glycaemic control, body mass index (BMI), gender and age of onset of diabetes...
Bisphosphonate space measurement and dosage requirement for intravenous clodronate treatment of Paget's diseaseM Rutland
Department of Nuclear Medicine, Auckland Hospital, Auckland, New Zealand
Calcif Tissue Int 70:99-102. 2002..Both ALP and the bisphosphonate space have wide prediction intervals, and are therefore poor guides to dose requirement...
Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatmentS Rudge
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland 1, New Zealand
Rheumatology (Oxford) 44:813-8. 2005..This study highlights the importance of differentiating between changes in bone size and changes in volumetric bone density in assessing bone in children, and also having control subjects in intervention studies...
Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's DiseaseNoriyoshi Kurihara
Department of Medicine/Hematology and Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
J Bone Miner Res 19:1154-64. 2004..TAFII-17 can bind VDR at low concentrations of 1,25(OH)2D3. These results suggest that MVNP expression in Paget's OCL precursors increases expression of a component(s) of the VDR transcription complex that can increase OCL formation...
(23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's diseaseSeiichi Ishizuka
Veterans Affairs Pittsburgh Healthcare System, Research and Development (151-U, University Drive, Pittsburgh, Pennsylvania 15240, USA
Endocrinology 146:2023-30. 2005..These results demonstrate that TEI-9647 can suppress the excessive bone resorption and OCL formation seen in marrow cultures from patients with PD...
Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cellsSeiichi Ishizuka
Department of Bone and Calcium Metabolism, Teijin Institute for Bio Medical Research, Hino, Tokyo, Japan
J Steroid Biochem Mol Biol 89:331-4. 2004..These results suggest that TEI-9647 acts directly on osteoclast precursors and osteoclasts, and that TEI-9647 may be a novel agent to suppress the excessive bone resorption and osteoclast formation in patients with Paget's disease...
Bisphosphonates and osteonecrosis of the jawAndrew Grey
Ann Intern Med 145:791; author reply 792. 2006
Why do poor outcomes persist in diabetic pregnancy?Tim Cundy
BMJ 333:304. 2006
Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerinAnna Daroszewska
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen AB25 2ZD, UK
J Bone Miner Res 19:1506-11. 2004..We found that the G1181 allele of TNFRSF11B, encoding lysine at codon 3 of the OPG protein, predisposes to both sporadic and familial PDB...
Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of boneGavin J A Lucas
Department of Medicine and Therapeutics, University of Aberdeen, UK
Bone 38:280-5. 2006..Genetic variation in VCP does not appear to be a common cause of familial or sporadic PDB in the absence of myopathy and dementia...
Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent MedicineBarbara A Cromer
Case School of Medicine, Cleveland, Ohio, USA
J Adolesc Health 39:296-301. 2006....
Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's diseaseWilliam E Friedrichs
Department of Medicine/Hematology, University of Texas Health Science Center, San Antonio, USA
J Bone Miner Res 17:145-51. 2002..These findings are consistent with the presence of a chronic MV infection in affected sites from these patients with Paget's disease...
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's diseaseLynne J Hocking
Department of Medicine and Therapeutics, University of Aberdeen, UK
Hum Mol Genet 11:2735-9. 2002..0001). These studies confirm that mutations affecting the ubiquitin-binding domain of SQSTM1 are a common cause of familial and sporadic Paget's disease of bone...
The deleted in colorectal carcinoma (DCC) gene 201 R --> G polymorphism: no evidence for genetic association with autoimmune diseaseRichard J Hall
Department of Biochemistry, University of Otago, Dunedin, New Zealand
Eur J Hum Genet 11:840-4. 2003..Thus, the DCC 201 R --> G polymorphism does not appreciably influence risk of developing the autoimmune diseases tested...
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequencesLynne J Hocking
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
J Bone Miner Res 19:1122-7. 2004..Functional and structural analysis showed that disease severity was related to the type of mutation but was unrelated to the polyubiquitin-binding properties of the mutant UBA domain peptides...
Defining vitamin D deficiencyMark J Bolland
N Z Med J 120:U2760. 2007
Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descentGavin Ja Lucas
Rheumatic Diseases Unit, University of Edinburgh, Edinburgh, United Kingdom
J Bone Miner Res 23:58-63. 2008..A major susceptibility locus for PDB was identified on chromosome 10p13 by a genome-wide linkage scan in families of British descent, which accounted for the vast majority of cases not caused by SQSTM1 mutations...
Recovery from skeletal fluorosisTim Cundy
J Bone Miner Res 22:1475; author reply 1476. 2007
Itraconazole-induced painful neuropathy in a man with type 1 diabetesRinki Singh
Diabetes Care 28:225. 2005
Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: evidence for a founder effect in patients of British descentGavin J A Lucas
Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
J Bone Miner Res 20:227-31. 2005..Here we show that the most common disease-causing mutation (P392L) is carried on a shared haplotype, consistent with a founder effect and a common ancestral origin...
